TY - JOUR AU - Bray, F. AU - Ferlay, J. AU - Soerjomataram, I. AU - Siegel, R. L. AU - Torre, L. A. AU - Jemal, A. PY - 2018 DA - 2018// TI - Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries JO - CA Cancer J Clin VL - 68 UR - https://doi.org/10.3322/caac.21492 DO - 10.3322/caac.21492 ID - Bray2018 ER - TY - JOUR AU - Fitzmaurice, C. AU - Akinyemiju, T. F. AU - Lami, F. H. AU - Alam, T. AU - Alizadeh-Navaei, R. PY - 2018 DA - 2018// TI - Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-Years for 29 Cancer Groups, 1990 to 2016: A Systematic Analysis for the Global Burden of Disease Study JO - JAMA Oncol VL - 4 UR - https://doi.org/10.1001/jamaoncol.2018.2706 DO - 10.1001/jamaoncol.2018.2706 ID - Fitzmaurice2018 ER - TY - JOUR AU - Sayles, L. C. AU - Breese, M. R. AU - Koehne, A. L. AU - Leung, S. G. AU - Lee, A. G. AU - Liu, H. Y. PY - 2019 DA - 2019// TI - Genome-informed targeted therapy for osteosarcoma JO - Cancer Discov. VL - 9 ID - Sayles2019 ER - TY - JOUR AU - Arab, A. AU - Behravan, N. AU - Razazn, A. AU - Barati, N. AU - Mosaffa, F. AU - Nicastro, J. PY - 2019 DA - 2019// TI - The viral approach to breast cancer immunotherapy JO - J Cell Physiol VL - 234 UR - https://doi.org/10.1002/jcp.27150 DO - 10.1002/jcp.27150 ID - Arab2019 ER - TY - JOUR AU - Wei, S. C. AU - Duffy, C. R. AU - Allison, J. P. PY - 2018 DA - 2018// TI - Fundamental mechanisms of immune checkpoint blockade therapy JO - Cancer Discov VL - 8 UR - https://doi.org/10.1158/2159-8290.CD-18-0367 DO - 10.1158/2159-8290.CD-18-0367 ID - Wei2018 ER - TY - JOUR AU - Zhang, Y. AU - Lun, L. AU - Li, H. AU - Wang, Q. AU - Lin, J. AU - Tian, R. PY - 2017 DA - 2017// TI - The value of lncRNA NEAT1 as a prognostic factor for survival of cancer outcome: a meta-analysis JO - Sci Rep VL - 7 UR - https://doi.org/10.1038/s41598-017-10001-0 DO - 10.1038/s41598-017-10001-0 ID - Zhang2017 ER - TY - JOUR AU - Tu, C. AU - Ren, X. AU - He, J. AU - Li, S. AU - Qi, L. AU - Duan, Z. PY - 2020 DA - 2020// TI - The predictive value of lncRNA MIR31HG expression on clinical outcomes in patients with solid malignant tumors JO - Cancer Cell Int VL - 20 UR - https://doi.org/10.1186/s12935-020-01194-y DO - 10.1186/s12935-020-01194-y ID - Tu2020 ER - TY - STD TI - Wang X, Ren M, Li Y, et al. Long noncoding RNA NNT-AS1 promotes gastric cancer proliferation and invasion by regulating microRNA-363 expression. J Cell Biochem. 2019;120(4):5704–12. ID - ref8 ER - TY - JOUR AU - Qi, P. AU - Du, X. PY - 2013 DA - 2013// TI - The long non-coding RNAs, a new cancer diagnostic and therapeutic gold mine JO - Mod Pathol VL - 26 UR - https://doi.org/10.1038/modpathol.2012.160 DO - 10.1038/modpathol.2012.160 ID - Qi2013 ER - TY - JOUR AU - He, J. AU - Tu, C. AU - Liu, Y. PY - 2018 DA - 2018// TI - Role of lncRNAs in aging and age-related diseases JO - Aging Med VL - 1 UR - https://doi.org/10.1002/agm2.12030 DO - 10.1002/agm2.12030 ID - He2018 ER - TY - JOUR AU - Liu, Y. AU - Lin, L. AU - Zou, R. AU - Wen, C. AU - Wang, Z. AU - Lin, F. PY - 2018 DA - 2018// TI - MSC-derived exosomes promote proliferation and inhibit apoptosis of chondrocytes via lncRNA-KLF3-AS1/miR-206/GIT1 axis in osteoarthritis JO - Cell Cycle VL - 17 UR - https://doi.org/10.1080/15384101.2018.1526603 DO - 10.1080/15384101.2018.1526603 ID - Liu2018 ER - TY - JOUR AU - Mehrad-Majd, H. AU - Akhtari, J. AU - Haerian, M. S. AU - Ravanshad, Y. PY - 2019 DA - 2019// TI - Clinicopathological and prognostic value of lncRNA PANDAR expression in solid tumors: evidence from a systematic review and meta-analysis JO - J Cell Physiol VL - 234 UR - https://doi.org/10.1002/jcp.27179 DO - 10.1002/jcp.27179 ID - Mehrad-Majd2019 ER - TY - JOUR AU - Zhang, C. AU - Ren, X. AU - He, J. AU - Wang, W. AU - Tu, C. AU - Li, Z. PY - 2019 DA - 2019// TI - The prognostic value of long noncoding RNA SNHG16 on clinical outcomes in human cancers: a systematic review and meta-analysis JO - Cancer Cell Int VL - 19 UR - https://doi.org/10.1186/s12935-019-0971-2 DO - 10.1186/s12935-019-0971-2 ID - Zhang2019 ER - TY - JOUR AU - Tu, C. AU - Ren, X. AU - He, J. AU - Zhang, C. AU - Chen, R. AU - Wang, W. PY - 2019 DA - 2019// TI - The value of LncRNA BCAR4 as a prognostic biomarker on clinical outcomes in human cancers JO - J Cancer VL - 10 UR - https://doi.org/10.7150/jca.35113 DO - 10.7150/jca.35113 ID - Tu2019 ER - TY - JOUR AU - Ye, H. AU - Lin, J. AU - Yao, X. AU - Li, Y. AU - Lin, X. AU - Lu, H. PY - 2018 DA - 2018// TI - Overexpression of long non-coding RNA NNT-AS1 correlates with tumor progression and poor prognosis in osteosarcoma JO - Cell Physiol Biochem VL - 45 UR - https://doi.org/10.1159/000487966 DO - 10.1159/000487966 ID - Ye2018 ER - TY - JOUR AU - Xiong, H. AU - Ni, Z. AU - He, J. AU - Jiang, S. AU - Li, X. AU - He, J. PY - 2017 DA - 2017// TI - LncRNA HULC triggers autophagy via stabilizing Sirt1 and attenuates the chemosensitivity of HCC cells JO - Oncogene. VL - 36 UR - https://doi.org/10.1038/onc.2016.521 DO - 10.1038/onc.2016.521 ID - Xiong2017 ER - TY - JOUR AU - Corra, F. AU - Agnoletto, C. AU - Minotti, L. AU - Baldassari, F. AU - Volinia, S. PY - 2018 DA - 2018// TI - The network of non-coding RNAs in cancer drug resistance JO - Front Oncol VL - 8 UR - https://doi.org/10.3389/fonc.2018.00327 DO - 10.3389/fonc.2018.00327 ID - Corra2018 ER - TY - JOUR AU - Lu, Y. B. AU - Jiang, Q. AU - Yang, M. Y. AU - Zhou, J. X. AU - Zhang, Q. PY - 2017 DA - 2017// TI - Long noncoding RNA NNT-AS1 promotes hepatocellular carcinoma progression and metastasis through miR-363/CDK6 axis JO - Oncotarget. VL - 8 UR - https://doi.org/10.18632/oncotarget.21321 DO - 10.18632/oncotarget.21321 ID - Lu2017 ER - TY - JOUR AU - Li, Y. AU - Lv, M. AU - Song, Z. AU - Lou, Z. AU - Wang, R. AU - Zhuang, M. PY - 2018 DA - 2018// TI - Long non-coding RNA NNT-AS1 affects progression of breast cancer through miR-142-3p/ZEB1 axis JO - Biomed Pharmacother VL - 103 UR - https://doi.org/10.1016/j.biopha.2018.04.087 DO - 10.1016/j.biopha.2018.04.087 ID - Li2018 ER - TY - JOUR AU - Gu, Y. AU - Li, C. AU - Xiao, L. AU - Li, J. AU - Pei, H. AU - Xu, D. PY - 2019 DA - 2019// TI - High expression of long non-coding RNA NNT-AS1 facilitates progression of cholangiocarcinoma through promoting epithelial-mesenchymal transition JO - Am J Transl Res VL - 11 ID - Gu2019 ER - TY - JOUR AU - Wang, Q. AU - Yang, L. AU - Hu, X. AU - Jiang, Y. AU - Hu, Y. AU - Liu, Z. PY - 2017 DA - 2017// TI - Upregulated NNT-AS1, a long noncoding RNA, contributes to proliferation and migration of colorectal cancer cells in vitro and in vivo JO - Oncotarget. VL - 8 UR - https://doi.org/10.18632/oncotarget.13840 DO - 10.18632/oncotarget.13840 ID - Wang2017 ER - TY - JOUR AU - Moher, D. AU - Shamseer, L. AU - Clarke, M. AU - Ghersi, D. AU - Liberati, A. AU - Petticrew, M. PY - 2015 DA - 2015// TI - Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement JO - Syst Rev VL - 4 UR - https://doi.org/10.1186/2046-4053-4-1 DO - 10.1186/2046-4053-4-1 ID - Moher2015 ER - TY - JOUR AU - Xu, L. AU - Yan, N. AU - Li, Z. AU - Luo, L. AU - Wu, X. AU - Liu, Q. PY - 2018 DA - 2018// TI - A comparison of fulvestrant plus a targeted agent with fulvestrant alone in hormone receptor-positive advanced breast cancer that progressed on prior endocrine therapy: a meta-analysis JO - OncoTargets Ther VL - 11 UR - https://doi.org/10.2147/OTT.S166653 DO - 10.2147/OTT.S166653 ID - Xu2018 ER - TY - JOUR AU - Stang, A. PY - 2010 DA - 2010// TI - Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses JO - Eur J Epidemiol VL - 25 UR - https://doi.org/10.1007/s10654-010-9491-z DO - 10.1007/s10654-010-9491-z ID - Stang2010 ER - TY - JOUR AU - Tang, Z. AU - Li, C. AU - Kang, B. AU - Gao, G. AU - Li, C. AU - Zhang, Z. PY - 2017 DA - 2017// TI - GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses JO - Nucleic Acids Res VL - 45 UR - https://doi.org/10.1093/nar/gkx247 DO - 10.1093/nar/gkx247 ID - Tang2017 ER - TY - JOUR AU - Huang, L. AU - Jiang, X. AU - Kang, P. AU - Wang, Z. AU - Leng, K. AU - Ji, D. PY - 2019 DA - 2019// TI - Long non-coding RNA NNT-AS1 functions as an oncogenic gene through modulating miR-485/BCL9 in cholangiocarcinoma JO - Cancer Manag Res VL - 11 UR - https://doi.org/10.2147/CMAR.S207801 DO - 10.2147/CMAR.S207801 ID - Huang2019 ER - TY - JOUR AU - Wu, D. AU - Zhang, T. AU - Wang, J. AU - Zhou, J. AU - Pan, H. AU - Qu, P. PY - 2019 DA - 2019// TI - Long noncoding RNA NNT-AS1 enhances the malignant phenotype of bladder cancer by acting as a competing endogenous RNA on microRNA-496 thereby increasing HMGB1 expression JO - Aging (Albany NY) VL - 11 UR - https://doi.org/10.18632/aging.102591 DO - 10.18632/aging.102591 ID - Wu2019 ER - TY - JOUR AU - Chen, B. AU - Zhao, Q. AU - Guan, L. AU - Lv, H. AU - Bie, L. AU - Huang, J. PY - 2018 DA - 2018// TI - Long non-coding RNA NNT-AS1 sponges miR-424/E2F1 to promote the tumorigenesis and cell cycle progression of gastric cancer JO - J Cell Mol Med VL - 22 UR - https://doi.org/10.1111/jcmm.13726 DO - 10.1111/jcmm.13726 ID - Chen2018 ER - TY - JOUR AU - Gu Youhua, X. F. AU - Xueping, Y. AU - Jian, Z. AU - Yueju, W. PY - 2018 DA - 2018// TI - Expression and clinical significance of LncRNA NNT-AS1 in gastric carcinoma JO - Shandong Med J VL - 58 ID - Gu Youhua2018 ER - TY - JOUR AU - Hua, F. AU - Liu, S. AU - Zhu, L. AU - Ma, N. AU - Jiang, S. AU - Yang, J. PY - 2017 DA - 2017// TI - Highly expressed long non-coding RNA NNT-AS1 promotes cell proliferation and invasion through Wnt/beta-catenin signaling pathway in cervical cancer JO - Biomed Pharmacother VL - 92 UR - https://doi.org/10.1016/j.biopha.2017.03.057 DO - 10.1016/j.biopha.2017.03.057 ID - Hua2017 ER - TY - STD TI - Li C, Zhang S, Qiu T, Wang Y, Ricketts DM, Qi C. Upregulation of long non-coding RNA NNT-AS1 promotes osteosarcoma progression by inhibiting the tumor suppressive miR-320a. Cancer Biol Ther. 2019;20(4):413–22. ID - ref31 ER - TY - JOUR AU - Huang, Y. AU - Shi, J. AU - Xu, Y. PY - 2018 DA - 2018// TI - Long non-coding RNA NNT-AS1 contributes to cell proliferation, metastasis and apoptosis in human ovarian cancer JO - Oncol Lett VL - 15 ID - Huang2018 ER - TY - JOUR AU - He, W. AU - Zhang, Y. AU - Xia, S. PY - 2020 DA - 2020// TI - LncRNA NNT-AS1 promotes non-small cell lung cancer progression through regulating miR-22-3p/YAP1 axis JO - Thorac Cancer VL - 11 UR - https://doi.org/10.1111/1759-7714.13280 DO - 10.1111/1759-7714.13280 ID - He2020 ER - TY - JOUR AU - Gu, Y. AU - Zhu, Z. AU - Pei, H. AU - Xu, D. AU - Jiang, Y. AU - Zhang, L. PY - 2020 DA - 2020// TI - Long non-coding RNA NNT-AS1 promotes cholangiocarcinoma cells proliferation and epithelial-to-mesenchymal transition through down-regulating miR-203 JO - Aging (Albany NY) VL - 12 UR - https://doi.org/10.18632/aging.102747 DO - 10.18632/aging.102747 ID - Gu2020 ER - TY - JOUR AU - Shen, Q. AU - Jiang, Y. PY - 2018 DA - 2018// TI - LncRNA NNT-AS1 promotes the proliferation, and invasion of lung cancer cells via regulating miR-129-5p expression JO - Biomed Pharmacother VL - 105 UR - https://doi.org/10.1016/j.biopha.2018.05.123 DO - 10.1016/j.biopha.2018.05.123 ID - Shen2018 ER - TY - JOUR AU - Cai, Y. D. Z. AU - Wang, J. Y. PY - 2018 DA - 2018// TI - LncRNA NNT-AS1 is a major mediator of cisplatin chemoresistance in non-small cell lung cancer through MAPK/slug pathway JO - Eur Rev Med Pharmacol Sci VL - 22 ID - Cai2018 ER - TY - JOUR AU - Tamang, S. AU - Acharya, V. AU - Roy, D. AU - Sharma, R. AU - Aryaa, A. AU - Sharma, U. PY - 2019 DA - 2019// TI - SNHG12: an LncRNA as a potential therapeutic target and biomarker for human Cancer JO - Front Oncol VL - 9 UR - https://doi.org/10.3389/fonc.2019.00901 DO - 10.3389/fonc.2019.00901 ID - Tamang2019 ER - TY - JOUR AU - Gao, Y. AU - Li, X. AU - Zhi, H. AU - Zhang, Y. AU - Wang, P. AU - Wang, Y. PY - 2019 DA - 2019// TI - Comprehensive characterization of somatic mutations impacting lncRNA expression for Pan-cancer JO - Mol Ther Nucleic Acids VL - 18 UR - https://doi.org/10.1016/j.omtn.2019.08.004 DO - 10.1016/j.omtn.2019.08.004 ID - Gao2019 ER - TY - JOUR AU - Minotti, L. AU - Agnoletto, C. AU - Baldassari, F. AU - Corra, F. AU - Volinia, S. PY - 2018 DA - 2018// TI - SNPs and somatic mutation on long non-coding RNA: new frontier in the cancer studies? JO - High Throughput VL - 7 UR - https://doi.org/10.3390/ht7040034 DO - 10.3390/ht7040034 ID - Minotti2018 ER - TY - JOUR AU - Care, A. AU - Bellenghi, M. AU - Matarrese, P. AU - Gabriele, L. AU - Salvioli, S. AU - Malorni, W. PY - 2018 DA - 2018// TI - Sex disparity in cancer: roles of microRNAs and related functional players JO - Cell Death Differ VL - 25 UR - https://doi.org/10.1038/s41418-017-0051-x DO - 10.1038/s41418-017-0051-x ID - Care2018 ER -